- Home
- LPTH vs MGTX Comparison
LPTH vs MGTX Comparison
Compare LPTH & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LPTH | MGTX |
|---|---|---|
| Founded | 1985 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 563.1M | 579.5M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | LPTH | MGTX |
|---|---|---|
| Price | $12.48 | $7.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $13.33 | ★ $23.83 |
| AVG Volume (30 Days) | ★ 3.6M | 406.6K |
| Earning Date | 02-11-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $52,787,353.00 | $27,417,000.00 |
| Revenue This Year | $69.00 | N/A |
| Revenue Next Year | $24.62 | $569.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 64.15 | ★ 96.83 |
| 52 Week Low | $1.61 | $4.55 |
| 52 Week High | $15.24 | $9.73 |
Technical Indicators
Market Signals| Indicator | LPTH | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 56.34 | 44.55 |
| Support Level | $9.80 | $7.22 |
| Resistance Level | $11.57 | $7.70 |
| Average True Range (ATR) | 1.37 | 0.39 |
| MACD | -0.06 | -0.02 |
| Stochastic Oscillator | 93.65 | 23.01 |
Price Performance
Historical ComparisonAbout LPTH LightPath Technologies Inc.
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.